All of Us study identifies thousands of new pharmacogenomic variants in diverse US population

Analysis of nearly 100,000 participants in the NIH All of Us programme has uncovered thousands of previously undescribed variants in genes governing drug response, with gains concentrated in populations historically underrepresented in genomic research.

Published · AI-drafted summary based on 1 public source
Illustration for pharmacogenomics story
Illustrative image — not from the source article.
Share

A large-scale pharmacogenomics study drawing on the NIH All of Us Research Programme has identified thousands of new genetic variants in genes that influence how individuals metabolise and respond to prescription medicines. The analysis, reported by STAT News on 11 November 2026, examined data from close to 100,000 participants and was notable for its demographic breadth, with the greatest number of novel discoveries arising from populations that have been underrepresented in previous pharmacogenomic reference datasets.

Pharmacogenomics — the study of how inherited variation shapes drug response — has historically relied on datasets skewed towards individuals of European ancestry. Researchers working with All of Us have argued that expanding diversity within the reference corpus is essential for ensuring that gene-drug interaction guidance is applicable across ancestry groups. The new findings add to a growing body of evidence that clinically relevant pharmacogenomic variants differ substantially in frequency between populations.

The study builds on earlier All of Us outputs, including a preprint published in late October 2026 that described long-read sequencing of 1,490 Hispanic and Latino participants and identified around ten million novel variants (covered previously by Genetic Current on 2 November 2026). The pharmacogenomics paper extends that diversity agenda into a domain with direct translational relevance: prescribing and drug safety. The original STAT News report did not name the journal of publication; further details are expected as the full paper becomes available.

Plain-language version

For patients, families, and general readers. Educational only — not medical advice.

Researchers studying the NIH All of Us programme — a large US health research project — have found thousands of previously unknown differences in genes that affect how people respond to medicines. The findings came from studying the DNA of nearly 100,000 people from a wide range of backgrounds. Many of the new discoveries involve populations whose genetic information has not been well represented in earlier research databases.

This matters because guidance on which medicines work well — or cause side effects — for a given person can depend in part on inherited gene variants. If those variants have never been studied in a particular population, the guidance may be less accurate for people from that group. Researchers say the new findings are a step towards making pharmacogenomics — the science of matching medicines to genetic make-up — more applicable across different ancestries.

This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source STAT News · 2026-11-11
    All of Us study finds thousands of new genetic variants affecting drug responses

Tags

pharmacogenomics all-of-us diverse-populations drug-response health-disparities population-genomics nih
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List